NTRK1 and neoplasm: Outside of neuronal growth and pain signaling, there is an increasing number of studies demonstrating that TrkA tumour-promoting signaling is present in several human cancers, including those of the breast [10], oral cavity [11], thyroid [13], cervix [43] and lung [14,15].